Salvatore Pepe PhD, BScHonsMed(Clin Pharm), GDipHealthCounsell, FCSANZ, FAHA, FESC Article Link
Assoc/Prof Salvatore Pepe is co-Leader of the Heart Research Group at the Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Australia. He is a co-Principal Investigator of a recently completed first-in-human clinical safety trial of cord blood cell therapy in neonates with Hypoplastic Left Heart Syndrome undergoing the Norwood-type cardiopulmonary bypass operation. With the primary aim to translate research innovation to clinical and surgical practice, his studies have focused on targeting mitochondrial and cellular metabolism, immune response and cardiac remodelling in myocardial injury, cardiomyopathy, heart failure, donor heart management in transplantation, and perioperative complications of cardiopulmonary bypass surgery. Current work is aimed at safe translation of cell therapy protocols to augment cardiac intervention outcomes in congenital and acquired heart conditions.
Read More
